2020-002010-41: A randomized, double-blind, placebo-controlled phase IIB study evaluating the efficacy of mesdopetam on DAILY on-time without troublesome dyskinesia in patients with Parkinson’s disease |
|
|
| Not yet recruiting | 2 | 140 | Europe | mesdopetam, IRL790, Capsule | Integrative Research Laboratories Sweden AB (IRLAB), Integrative Research Laboratories Sweden AB, Integrative Research Laboratories Sweden AB (IRLAB)s, Integrative Research Laboratories AB (IRLAB) | Parkinson's disease dyskinesia, Parkinson's disease dyskinesia refers to a group of involuntary movement disorders. Dyskinesia can be anything from a slight tremor of the handds to an uncontrollable movement of the body., Diseases [C] - Nervous System Diseases [C10] | | | | |
